Abbott Laboratories Revenue 2006-2019 | ABT

Abbott Laboratories annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Abbott Laboratories revenue for the quarter ending December 31, 2019 was $8.314B, a 7.07% increase year-over-year.
  • Abbott Laboratories revenue for the twelve months ending December 31, 2019 was $31.904B, a 4.34% increase year-over-year.
  • Abbott Laboratories annual revenue for 2019 was $31.904B, a 4.34% increase from 2018.
  • Abbott Laboratories annual revenue for 2018 was $30.578B, a 11.64% increase from 2017.
  • Abbott Laboratories annual revenue for 2017 was $27.39B, a 31.35% increase from 2016.
Abbott Laboratories Annual Revenue
(Millions of US $)
2019 $31,904
2018 $30,578
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
2010 $35,167
2009 $30,765
2008 $29,528
2007 $25,914
2006 $22,476
2005 $22,338
Abbott Laboratories Quarterly Revenue
(Millions of US $)
2019-12-31 $8,314
2019-09-30 $8,076
2019-06-30 $7,979
2019-03-31 $7,535
2018-12-31 $7,765
2018-09-30 $7,656
2018-06-30 $7,767
2018-03-31 $7,390
2017-12-31 $7,589
2017-09-30 $6,829
2017-06-30 $6,637
2017-03-31 $6,335
2016-12-31 $5,333
2016-09-30 $5,302
2016-06-30 $5,333
2016-03-31 $4,885
2015-12-31 $5,188
2015-09-30 $5,150
2015-06-30 $5,170
2015-03-31 $4,897
2014-12-31 $5,356
2014-09-30 $5,079
2014-06-30 $5,057
2014-03-31 $4,755
2013-12-31 $4,008
2013-09-30 $4,825
2013-06-30 $5,446
2013-03-31 $5,378
2012-12-31 $3,188
2012-09-30 $5,265
2012-06-30 $5,313
2012-03-31 $5,284
2011-12-31 $10,377
2011-09-30 $9,817
2011-06-30 $9,616
2011-03-31 $9,041
2010-12-31 $9,968
2010-09-30 $8,675
2010-06-30 $8,826
2010-03-31 $7,698
2009-12-31 $8,790
2009-09-30 $7,761
2009-06-30 $7,495
2009-03-31 $6,718
2008-12-31 $7,950
2008-09-30 $7,498
2008-06-30 $7,314
2008-03-31 $6,766
2007-12-31 $7,221
2007-09-30 $6,377
2007-06-30 $6,371
2007-03-31 $5,946
2006-12-31 $6,821
2006-09-30 $5,574
2006-06-30 $5,501
2006-03-31 $4,580
2005-12-31 $6,047
2005-09-30 $5,384
2005-06-30 $5,524
2005-03-31 $5,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $145.889B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.096B 16.95
Stryker (SYK) United States $62.094B 20.06
Boston Scientific (BSX) United States $45.907B 20.68
Baxter (BAX) United States $43.082B 26.29
Coloplast (CLPBY) Denmark $31.666B 48.87
Lonza Group Ag (LZAGY) Switzerland $30.808B 0.00
Terumo (TRUMY) Japan $25.125B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $24.988B 0.00
ResMed (RMD) United States $22.893B 39.77
Zimmer Biomet Holdings (ZBH) United States $20.215B 12.44
Smith & Nephew SNATS (SNN) United Kingdom $15.935B 0.00
Sunny Optical Technology (SNPTF) China $14.665B 0.00
Bio-Rad Laboratories (BIO) United States $11.410B 53.33
Insulet (PODD) United States $10.806B 661.15
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.302B 21.00
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
Perrigo (PRGO) Ireland $6.476B 11.80
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Haemonetics (HAE) United States $5.142B 31.65
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Canopy Growth (CGC) Canada $5.010B 0.00
ICU Medical (ICUI) United States $4.301B 28.09
Quidel (QDEL) United States $4.034B 35.41
Neogen (NEOG) United States $3.598B 60.95
Agios Pharmaceuticals (AGIO) United States $2.706B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.438B 0.00
NuVasive (NUVA) United States $2.419B 18.71
Envista Holdings (NVST) United States $2.275B 0.00
National Vision Holdings (EYE) United States $1.476B 24.86
AtriCure (ATRC) United States $1.368B 0.00
Cardiovascular Systems (CSII) United States $1.302B 0.00
TG Therapeutics (TGTX) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.986B 19.50
Aurora Cannabis (ACB) Canada $0.973B 0.00
NanoString Technologies (NSTG) United States $0.921B 0.00
VAREX IMAGING (VREX) United States $0.835B 17.34
Aphria (APHA) $0.802B 0.00
Cerus (CERS) United States $0.788B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.757B 136.15
Omeros (OMER) United States $0.752B 0.00
InMode (INMD) Israel $0.709B 0.00
OraSure Technologies (OSUR) United States $0.689B 85.46
PetIQ (PETQ) United States $0.675B 18.38
Eagle Pharmaceuticals (EGRX) United States $0.647B 38.48
Quanterix (QTRX) United States $0.596B 0.00
LeMaitre Vascular (LMAT) United States $0.490B 27.59
Surmodics (SRDX) United States $0.455B 52.30
Lantheus Holdings (LNTH) United States $0.440B 9.90
Owens & Minor (OMI) United States $0.427B 11.67
Meridian Bioscience (VIVO) United States $0.380B 15.31
Zynex (ZYXI) United States $0.371B 39.96
Vapotherm (VAPO) United States $0.367B 0.00
Repro-Med Systems (KRMD) United States $0.337B 212.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Organigram Holdings (OGI) Canada $0.296B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.220B 0.00
BioLife Solutions (BLFS) United States $0.210B 128.63
Female Health (VERU) United States $0.203B 0.00
HEXO (HEXO) $0.197B 0.00
InfuSystems Holdings (INFU) United States $0.191B 159.67
Exagen (XGN) United States $0.170B 0.00
Viemed Healthcare (VMD) United States $0.169B 19.13
Rockwell Medical (RMTI) United States $0.144B 0.00
United Health Products (UEEC) United States $0.140B 0.00
Evolus (EOLS) United States $0.131B 0.00
Bovie Medical (APYX) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.110B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.107B 0.00
Fonar (FONR) United States $0.097B 7.08
Chimerix (CMRX) United States $0.086B 0.00
Brainsway (BWAY) Israel $0.082B 0.00
MTech Acquisition (KERN) United States $0.079B 0.00
United-Guardian (UG) United States $0.063B 13.17
Green Organic Dutchman Holdings (TGODF) Canada $0.062B 0.00
Nephros (NEPH) United States $0.060B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00